Literature DB >> 34628012

Developing and validating a modified enzyme linked immunosorbent assay method for detecting HEV IgG antibody from dried blood spot (DBS) samples in endemic settings.

Rosy Sultana1, Taufiqur Rahman Bhuiyan2, Afsana Shirin Sathi2, Salma Sharmin2, Sharmina Yeasmin3, Muhammad Ikhtear Uddin2, Md Saruar Bhuiyan2, Kaiissar Mannoor4, Muhammad Manjurul Karim5, K Zaman2, Firdausi Qadri6.   

Abstract

Serological analysis is an integral part of laboratory practice nowadays. The present study was aimed to develop and validate a modified Enzyme linked Immunosorbent Assay (ELISA) for determination of IgG antibody against Hepatitis E Virus (HEV) using dried blood spots (DBS) and corresponding plasma samples. A total of 65 samples (45 HEV patients, 20 healthy controls) were analyzed. DBS and plasma samples demonstrated equivalent optical densities for detecting anti-HEV IgG. A highly significant correlation was observed between plasma and DBS sample absorbances (R2 = 0.98; p < 0.001) at dilution 1:200, indicating true agreement between the two procedures. The assay exhibited decent linearity and showed no effect of physiological hematocrit on assay performance. Data suggested recommendable promise in using DBS as a suitable alternative to plasma samples to determine HEV IgG antibody evidenced by significant correlation with plasma results. Therefore, identical method for processing DBS specimens including it's proper storage is recommended for implementation of a modified ELISA in different settings.
Copyright © 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34628012      PMCID: PMC8960178          DOI: 10.1016/j.micinf.2021.104890

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  28 in total

1.  Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis.

Authors:  G R Reyes; M A Purdy; J P Kim; K C Luk; L M Young; K E Fry; D W Bradley
Journal:  Science       Date:  1990-03-16       Impact factor: 47.728

2.  The use of dried blood spots for assessing antibody response to hepatitis A virus after natural infection and vaccination.

Authors:  J G Melgaço; M A Pinto; A M Rocha; M Freire; L P Gaspar; S M B Lima; O G Cruz; C L Vitral
Journal:  J Med Virol       Date:  2011-02       Impact factor: 2.327

3.  Screening for sickle cell disease on dried blood: a new approach evaluated on 27,000 Belgian newborns.

Authors:  François Boemer; Jean-François Vanbellinghen; Vincent Bours; Roland Schoos
Journal:  J Med Screen       Date:  2006       Impact factor: 2.136

4.  Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots.

Authors:  Ali Judd; John Parry; Matthew Hickman; Tamara McDonald; Laura Jordan; Kim Lewis; Marcela Contreras; Geoff Dusheiko; Graham Foster; Noël Gill; Katie Kemp; Janice Main; Iain Murray-Lyon; Mark Nelson
Journal:  J Med Virol       Date:  2003-09       Impact factor: 2.327

5.  Seroprevalence of subclinical HEV infection in pregnant women from north India: a hospital based study.

Authors:  Nargis Begum; Salam Gyaneshwori Devi; Syed A Husain; P Kar
Journal:  Indian J Med Res       Date:  2009-12       Impact factor: 2.375

6.  Outbreak of hepatitis E virus infection in Darfur, Sudan: effectiveness of real-time reverse transcription-PCR analysis of dried blood spots.

Authors:  Audrey Mérens; Philippe Jean Guérin; Jean-Paul Guthmann; Elisabeth Nicand
Journal:  J Clin Microbiol       Date:  2009-04-01       Impact factor: 5.948

7.  Innate immune responses in human hepatocyte-derived cell lines alter genotype 1 hepatitis E virus replication efficiencies.

Authors:  Pradip B Devhare; Swapnil Desai; Kavita S Lole
Journal:  Sci Rep       Date:  2016-05-27       Impact factor: 4.379

Review 8.  Hepatitis E Virus Mutations: Functional and Clinical Relevance.

Authors:  Hoang van Tong; Nghiem Xuan Hoan; Bo Wang; Heiner Wedemeyer; C-Thomas Bock; Thirumalaisamy P Velavan
Journal:  EBioMedicine       Date:  2016-08-06       Impact factor: 8.143

9.  Validation of an Optimized ELISA for Quantitative Assessment of Epstein-Barr Virus Antibodies from Dried Blood Spots.

Authors:  Geeta Eick; Samuel S Urlacher; Thomas W McDade; Paul Kowal; J Josh Snodgrass
Journal:  Biodemography Soc Biol       Date:  2016

10.  Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome.

Authors:  A W Tam; M M Smith; M E Guerra; C C Huang; D W Bradley; K E Fry; G R Reyes
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.